Psychiatry

Publications

Althoff, RR; Singh, MK; Stringaris, A; Constantino, JN; Amaya-Jackson, L; Benton, TD; Bellonci, C; Bostic, JQ; Chua, JD; Findling, RL; McClellan, JM; Sorter, MT; Waxmonsky, JG; Carlson, GA. Research Agenda in Childhood Impairing Emotional Outbursts: A Report of the AACAP Presidential Taskforce on Emotional Dysregulation. 2025; 3:147-155.

Argonis, RA; Pedapati, EV; Dominick, KC; Harris, K; Lamy, M; Fosdick, C; Schmitt, L; Shaffer, RC; Smith, E; Will, M; McDougle, CJ; Erickson, CA. Patterns in Medication Use for Treatment of Depression in Autistic Spectrum Disorder. Journal of Autism and Developmental Disorders. 2025; 55:1969-1975.

Berry-Kravis, E; Erickson, C. Fragile X Syndrome. Neuropsychiatric Care for Genetic Syndromes and Other Neurodevelopmental Disorders. : Springer Nature; Springer Nature; 2025.

Blank, E; Gilbert, DL; Wu, SW; Larsh, T; Elmaghraby, R; Liu, R; Smith, E; Westerkamp, G; Liu, Y; Horn, PS; Greenstein, E; Sweeney, JA; Erickson, CA; Pedapati, EV. Accelerated Theta Burst Transcranial Magnetic Stimulation for Refractory Depression in Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. 2025; 55:940-954.

Brown, ES; Nery, FG; Haller, K; Gardner, SM. Escitalopram-Associated Drug Rash: A Case Report. Journal of Clinical Psychopharmacology. 2025; 45:683-685.

Chang, X; Li, W; Matsui, S; Huynh, C; Erickson, C; Guo, F; Cederquist, GY; Studer, L; Iwafuchi, M; Shillington, A; Chronis, C; Tchieu, J. ZMYND11 functions in bimodal regulation of latent genes and brain-like splicing to safeguard corticogenesis. Nature Communications. 2025; 16:9010.

Cho, W; Kobayashi, M; Kambara, H; Tanaka, H; Kagawa, T; Sato, M; Kim, H; Miyakoshi, M; Makeig, S; Iversen, J; Yoshimura, N. (2025) Enhancing Juggling Proficiency Through Slow-Tempo Virtual Reality Training. Institute of Electrical and Electronics Engineers (IEEE). 0:904-910.

Citarella, J; Siekierski, P; Ethridge, L; Westerkamp, G; Liu, Y; Blank, E; Voorhees, L; Batterink, L; Jones, SR; Smith, E; Horn, PS; De Stefano, LA; Erickson, CA; Pedapati, EV. FX ENTRAIN: scientific context, study design, and biomarker driven brain-computer interfaces in neurodevelopmental conditions. Frontiers in Neuroscience. 2025; 19:1618804.

Combs, J; Lin, PI; DelBello, MP; Carle, AC; Bridge, JA; Axelson, DA; Fornari, V; Feuer, V; Emslie, GJ; Kennard, BD; Porter, SC; Sorter, MT; Barzman, D. Examining Alternative Treatment Settings for Adolescents With Suicidal Thoughts During the COVID-19 Pandemic. 2025; 3:567-575.

DelBello, MP; Kurtz, BP. 53.4 Metformin for Overweight and Obese Children With Bipolar Spectrum Disorders Treated With Second-Generation Antipsychotics: 24-Month Outcomes. Journal of the American Academy of Child and Adolescent Psychiatry. 2025; 64:s413-s414.

DelBello, MP; Welge, JA; Klein, CC; Blom, TJ; Fornari, V; Higdon, C; Sorter, MT; Kurtz, B; Starr, C; Smith, A; Huang, B; Chen, C; Modi, AC; Crimmins, N; Correll, CU. Metformin for overweight and obese children and adolescents with bipolar spectrum and related mood disorders treated with second-generation antipsychotics: a randomised, pragmatic trial. The Lancet Psychiatry. 2025; 12:893-905.

Edwards, R; Murphy, G; Owens, JW; Erickson, C; Hopkin, R; Shillington, A. Dual Diagnosis of Fragile X Syndrome and DEPDC5-Related Disorder Emphasizes DEPDC5's Role Beyond Familial Epilepsy: A Case Report and Literature Review. Editor, Das SP. Case Reports in Genetics. 2025; 2025:4501466.

Elmaghraby, R; Blank, E; Miyakoshi, M; Gilbert, DL; Wu, SW; Larsh, T; Westerkamp, G; Liu, Y; Horn, PS; Erickson, CA; Pedapati, EV. Probing the Neurodynamic Mechanisms of Cognitive Flexibility in Depressed Individuals with Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology. 2025; 35:231-243.

Elmaghraby, R; Liu, Y; Ramesh, P; Westerkamp, G; Nelson, MA; Larsh, T; Smith, E; Gilbert, DL; Wu, SW; Erickson, CA; Pedapati, EV. Divergent aperiodic slope and alpha dynamics expose cortical excitability gradients in fragile X syndrome. Molecular Autism. 2025; 16:49.

Erickson, CA; Shaffer, RC; Will, M; Schmitt, LM; Horn, P; Hirst, K; Pedapati, EV; Ober, N; Tumuluru, RV; Handen, BL; Beversdorf, DQ. Brief Report: A Double-Blind, Placebo-Controlled, Crossover, Proof-of-Concept Study of Minocycline in Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. 2025; 55:3387-3394.

Gaulden, AD; Tepe, EA; Sia, E; Rollins, SS; McReynolds, JR. Repeated footshock stress enhances cocaine self-administration in male and female rats: Role of the cannabinoid receptor 1. Physiology and Behavior. 2025; 293:114840.

Harris, K; Fosdick, C; Zappia, KJ; Dominick, KC; Lamy, M. Safety and Effectiveness of Clozapine in Youth and Young Adults with Neurodevelopmental Disorders and Severe, Treatment-Refractory Irritability and Aggression: A Retrospective Chart Review. Journal of Child and Adolescent Psychopharmacology. 2025; 35:337-346.

Henneberry, EA; Erickson, CA. Alpha-2 Agonists in Autism Spectrum Disorder. Lifespan Treatment for Autistic Individuals. : Oxford University Press (OUP); Oxford University Press (OUP); 2025.

Higdon, C; Welge, JA; Crimmins, NA; Klein, CC; Fornari, VM; Sorter, MT; Blom, TJ; Kurtz, BP; Correll, CU; DelBello, MP. Metabolic syndrome in youth with bipolar spectrum disorders treated with second-generation antipsychotics: baseline results from the community-based pragmatic MOBILITY Trial. European Child and Adolescent Psychiatry: official journal of the European Society for Child and Adolescent Psychiatry. 2025; 34:2917-2929.

Kanbar, LJ; Osborn, A; Cifuentes, A; Combs, J; Sorter, M; Barzman, D; Dexheimer, JW. Forecasting school violence risk with incomplete interview data: an automated assessment approach. JAMIA Open. 2025; 8:ooaf084.

Kehinde, O; Vaughn, SE; Amaeze, O; Toren, P; Retke, B; Oni-Orisan, A; Ramsey, LB. Cytochrome P450 2D6 *17 and *29 Allele Activity for Risperidone Metabolism: Advancing Precision Medicine Health Equity. Clinical Pharmacology and Therapeutics. 2025; 118:1152-1160.

Kim, H; Chang, CY; Kothe, C; Iversen, JR; Miyakoshi, M. Juggler's ASR: Unpacking the principles of artifact subspace reconstruction for revision toward extreme MoBI. Journal of Neuroscience Methods. 2025; 420:110465.

Lin, PD; Combs, J; DelBello, MP; Bridge, J; Axelson, D; Fornari, VM; Feuer, V; Kennard, BD; Emslie, GJ; Carle, AC; Barzman, DH. 5.44 Harnessing Cumulative Risk Scores to Identify Optimal Treatment Settings for Suicidal Adolescents. Journal of the American Academy of Child and Adolescent Psychiatry. 2025; 64:s290.

Magnusen, AF; Hopkin, RJ; Vorhees, C; Wilson, E; Moehlman, M; Hallinan, B; Erickson, C; DelBello, MP; Marsili, L; Coufal, NG; Pandey, MK. Emerging role of complement system in the induction of neuroinflammation in adenylosuccinate lyase deficiency disorder. Brain, Behavior, and Immunity - Health. 2025; 48:101091.

McClure, JM; Mara, CA; Stark, LJ; Anderson, J; Young, M; Aggarwal, A; Harris, E; Modi, AC. The Influence of Project ECHO and Integrated Behavioral Health in Primary Care on Emergency Department Visits Among Youth Diagnosed with Depression. The Journal of Behavioral Health Services & Research. 2025; 52:357-366.

McKinney, WS; Corsmeier, A; Dapore, A; Gross, C; Dominick, KC; Erickson, CA; Schmitt, LM. Beyond the Fragile X protein: neighborhood characteristics explain individual differences in IQ and adaptive behaviors of Fragile X syndrome. Frontiers in Psychiatry. 2025; 16:1636987.

McKinney, WS; Schmitt, LM; De Stefano, LA; Ethridge, L; Norris, JE; Horn, PS; Dauterman, S; Rosselot, H; Pedapati, EV; Reisinger, DL; Friedman, NR; Hong, M; Sweeney, JA; Erickson, C. Results from a Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Crossover Trial of Lovastatin or Minocycline in Fragile X Syndrome. Journal of Child and Adolescent Psychopharmacology. 2025; 35:211-221.

Miyakoshi, M; Jurgiel, J; Dillon, A; Piacentini, J; Makeig, S; Loo, SK. EEG power modulation in the sensorimotor regions is critical to motor tic suppression. Frontiers in Psychiatry. 2025; 16:1580636.

Miyakoshi, M; Kim, H; De Stefano, LA; Schmitt, LM; Norris, JE; Ethridge, LE; Erickson, CA; Pedapati, EV. Hyper-extralemniscal model of Fragile X syndrome. Cerebral Cortex. 2025; 35:bhaf141.

Nelson, MA; Shaffer, RC; Schmitt, LM; Coffman, MC; Horn, PS; Reisinger, DL; Erickson, CA. Health Related Quality of Life in Autistic Youth and Their Families. Journal of Autism and Developmental Disorders. 2025; 55:1982-1987.

Oberman, LM; Berry-Kravis, E; Budimirovic, DB; Erickson, CA; Hagerman, RJ; Harris, HK; Hessl, D; Lozano, R; Thurm, A; Tartaglia, N; Tran, J; Kaufmann, WE. The Aberrant Behavior Checklist for Fragile X Syndrome: A Qualitative Clinician Evaluation of Content Validity. Journal of Child and Adolescent Psychopharmacology. 2025; 35:399-415.

Pedapati, EV; Ethridge, LE; Liu, Y; Liu, R; Sweeney, JA; DeStefano, LA; Miyakoshi, M; Razak, K; Schmitt, LM; Moore, DR; Dominick, KC; Horn, PS; Binder, D; Erickson, CA. Frontal cortex hyperactivation and gamma desynchrony in Fragile X syndrome: Correlates of auditory hypersensitivity. Editor, Narmashiri A. PloS one. 2025; 20:e0306157.

Pedicini, N; Nashawi, H; Buesing, D; Gaulden, A; McReynolds, J; Ulrich-Lai, Y. The Effect of Palatable Food Reward and Restraint Stress on In Vivo Neuronal Activity in the Basolateral Amygdala (Abstract ID: 169783). The Journal of pharmacology and experimental therapeutics. 2025; 392:101087.

Saito, E; Nikolov, R; Sorter, MT; Edwards, S; Goetz, JL; Iagaru, G; Isaza, LC; Syed, EU; Taylor, RV. Systematic Search and Review: Management and Prevention of Agitation and Aggression in the Child and Adolescent Psychiatric Inpatient Setting. Journal of Child and Adolescent Psychopharmacology. 2025; 35:375-387.

Santhan Ramesh Kumar Padma, MP; Elmaghraby, R; Pedapati, E; Blank, EJ; Erickson, CA. Cognitive Flexibility in Autism: New Tools for Understanding and Treatment. Journal of the American Academy of Child and Adolescent Psychiatry. 2025; 64:s335.

Siegel, M; Goldfeder, N; Romani, P; Lamy, M. Raising the Bar: Growth of Specialized Hospital Psychiatric Units for Youths With Neurodevelopmental Disabilities. Psychiatric Services. 2025; 76:1050-1056.

Soe, KC; Arnold, MJ; Smith, JR; Dominick, KC. Is Pediatric Catatonia on the Rise?. Hospital Pediatrics. 2025; 15:e449-e452.

Stimpfl, JN; Soe, KC. Transdermal Asenapine for Agitation and Irritability in a Child With Complete Intravenous Dependence. Journal of the American Academy of Child and Adolescent Psychiatry. 2025; 64:89-91.

Stimpfl, JN; Walkup, JT; Robb, AS; Alford, AE; Stahl, SM; McCracken, JT; Stancil, SL; Ramsey, LB; Emslie, GJ; Strawn, JR. Deprescribing Antidepressants in Children and Adolescents: A Systematic Review of Discontinuation Approaches, Cross-Titration, and Withdrawal Symptoms. Journal of Child and Adolescent Psychopharmacology. 2025; 35:3-22.

Vaughn, A; Daraiseh, NM; Aeschbury, M; Backman, C; Liu, C; Sorter, M; Macaluso, M. Screening tool for predicting patient aggressive behavior and staff injury at a pediatric hospital. Journal of Psychiatric Research. 2025; 186:373-378.

Zappia, KJ; Erickson, CA. Psychopharmacology in Autism. Handbook of Evidence Based Practices in Autism Spectrum Disorder. 2025.

Zappia, KJ; Erickson, CA. Psychopharmacology in Autism. Handbook of Evidence-Based Practices in Autism Spectrum Disorder. : Springer Nature; Springer Nature; 2025.